Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,292 | 5 | 58.7% |
| Food and Beverage | $6,821 | 203 | 19.7% |
| Unspecified | $4,625 | 3 | 13.4% |
| Travel and Lodging | $2,740 | 15 | 7.9% |
| Education | $92.99 | 1 | 0.3% |
| Entertainment | $14.76 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cardinal Health 108 LLC | $18,075 | 17 | $0 (2020) |
| Allergan, Inc. | $5,824 | 29 | $0 (2020) |
| Alimera Sciences, Inc. | $5,787 | 50 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $825.86 | 19 | $0 (2024) |
| Genentech USA, Inc. | $614.98 | 18 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $579.14 | 16 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $513.50 | 12 | $0 (2024) |
| ABBVIE INC. | $365.48 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $345.41 | 6 | $0 (2021) |
| Biogen, Inc. | $342.29 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $875.93 | 30 | Apellis Pharmaceuticals, Inc. ($215.15) |
| 2023 | $1,138 | 36 | AbbVie Inc. ($171.20) |
| 2022 | $914.55 | 34 | Alimera Sciences, Inc. ($252.20) |
| 2021 | $963.56 | 27 | Mallinckrodt Hospital Products Inc. ($301.58) |
| 2020 | $6,520 | 13 | Cardinal Health 108 LLC ($6,225) |
| 2019 | $9,493 | 22 | Cardinal Health 108, LLC ($8,864) |
| 2018 | $9,764 | 53 | Allergan Inc. ($5,702) |
| 2017 | $4,917 | 13 | Alimera Sciences, Inc. ($4,458) |
All Payment Transactions
228 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug), YUTIQ | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 11/20/2024 | Harrow Eye, LLC | IHEEZO (Drug), TRIESENCE | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: OPTOMETRY | ||||||
| 11/14/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $32.07 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $31.29 | General |
| Category: Ophthalmology | ||||||
| 11/04/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $41.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/10/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: Ophthalmology | ||||||
| 08/27/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/14/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Ophthalmology | ||||||
| 07/10/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Ophthalmology | ||||||
| 07/09/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $33.34 | General |
| Category: Ophthalmology | ||||||
| 07/02/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: EYE CARE | ||||||
| 06/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: IMMUNOLOGY | ||||||
| 06/17/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: Ophthalmology | ||||||
| 06/11/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: Ophthalmology | ||||||
| 06/03/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: Ophthalmology | ||||||
| 05/29/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $113.03 | General |
| Category: Ophthalmology | ||||||
| 05/21/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Ophthalmology | ||||||
| 05/14/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: Ophthalmology | ||||||
| 04/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.04 | General |
| Category: IMMUNOLOGY | ||||||
| 04/02/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Ophthalmology | ||||||
| 03/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: OPHTHALMOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PALADIN | Alimera Sciences, Inc. | $4,625 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,922 | 11,698 | $2.9M | $1.1M |
| 2022 | 14 | 1,844 | 5,639 | $3.1M | $1.1M |
| 2021 | 13 | 1,881 | 5,816 | $3.5M | $1.3M |
| 2020 | 14 | 2,008 | 5,963 | $3.9M | $1.5M |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 92 | 622 | $1.2M | $430,200 | 36.0% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 54 | 895 | $461,820 | $194,426 | 42.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 17 | 5,880 | $447,586 | $168,891 | 37.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 403 | 966 | $171,297 | $60,300 | 35.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 175 | 703 | $167,914 | $59,467 | 35.4% |
| 92134 | Imaging of retina | Office | 2023 | 535 | 1,586 | $131,330 | $45,338 | 34.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 334 | 502 | $127,292 | $41,498 | 32.6% |
| J3590 | Unclassified biologics | Office | 2023 | 23 | 38 | $100,844 | $41,123 | 40.8% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 11 | 165 | $49,620 | $19,860 | 40.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 79 | 79 | $23,961 | $7,550 | 31.5% |
| 92250 | Photography of the retina | Office | 2023 | 83 | 111 | $11,357 | $2,990 | 26.3% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 17 | 17 | $3,233 | $1,575 | 48.7% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 15 | 22 | $8,800 | $1,180 | 13.4% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 62 | 70 | $4,200 | $1,153 | 27.5% |
| 67515 | Injection of drug or substance into membrane covering eyeball | Office | 2023 | 11 | 15 | $2,395 | $542.43 | 22.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 27 | $86.40 | $21.08 | 24.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 128 | 1,100 | $2.1M | $791,544 | 37.5% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 20 | 406 | $295,790 | $91,387 | 30.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 393 | 1,032 | $182,570 | $64,612 | 35.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 162 | 682 | $162,616 | $57,962 | 35.6% |
| 92134 | Imaging of retina | Office | 2022 | 538 | 1,609 | $133,423 | $46,762 | 35.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 324 | 465 | $118,203 | $39,004 | 33.0% |
| 67210 | Destruction of growth of retina using a laser | Office | 2022 | 20 | 27 | $28,915 | $10,636 | 36.8% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2022 | 12 | 12 | $28,048 | $10,460 | 37.3% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 87 | 87 | $26,506 | $9,415 | 35.5% |
About Dr. Jon Adleberg, M.D
Dr. Jon Adleberg, M.D is a Specialist healthcare provider based in Chesapeake, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710981246.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Adleberg, M.D has received a total of $34,587 in payments from pharmaceutical and medical device companies, with $875.93 received in 2024. These payments were reported across 228 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($20,292).
As a Medicare-enrolled provider, Adleberg has provided services to 7,655 Medicare beneficiaries, totaling 29,116 services with total Medicare billing of $5.0M. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Specialist, Ophthalmology
- Location Chesapeake, VA
- Active Since 06/13/2005
- Last Updated 05/15/2017
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1710981246
Products in Payments
- OZURDEX (Drug) $6,092
- ILUVIEN (Biological) $4,375
- ILUVIEN (Drug) $603.12
- ACTHAR (Biological) $599.72
- Iluvien (Drug) $459.77
- EYLEA (Biological) $427.13
- EYLEA AFLIBERCEPT INJECTION (Biological) $398.73
- Syfovre (Drug) $367.82
- Cimerli (Biological) $354.48
- Lucentis (Biological) $292.76
- Vabysmo (Drug) $287.81
- BEOVU (Drug) $236.10
- Spectralis (Device) $214.86
- BYOOVIZ (Biological) $152.55
- XIPERE (Drug) $148.27
- ForeseeHome (Device) $133.22
- Jetrea (Drug) $83.26
- Iluvien (Biological) $83.25
- ARGOS (Device) $57.07
- YUTIQ (Drug) $48.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Chesapeake
Neil Pugach, M.d, M.D
Specialist — Payments: $332,896
Dr. David Goss, M.d, M.D
Specialist — Payments: $18,099
Mrs. Patricia King, M.d, M.D
Specialist — Payments: $13,267
Stephanie Marioneaux, M.d, M.D
Specialist — Payments: $6,855
Idalia Rosado-Torres, M.d, M.D
Specialist — Payments: $5,321
Gilbert Snider, M.d, M.D
Specialist — Payments: $2,948